Quotient (QTNT) Reports Q3 Loss of $0.48
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
UBS Reiterates Buy as Quotient (QTNT) Believes Bulk of MosaiQ Development Risk is Complete
February 9, 2016 9:16 AM ESTUBS maintained a Buy rating on Quotient (NASDAQ: QTNT), and cut the price target to $25.00 (from $26.00), following the company's 3Q earnings report. F3Q16 featured meaningful progress, execution, and updates to the MosaiQ. Management reiterated plans on the earnings call to enter field trials in the US and EU. Management believes the bulk of the development risk for MosaiQ is... More
Quotient (QTNT) 4.4M Offering Prices at $9/Share
February 5, 2016 7:36 AM ESTQuotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, announced the pricing of an underwritten public offering of 4,444,445 of its ordinary shares at a price to the public of $9.00 per share. The net proceeds to Quotient from this offering are expected to be $36.9 million, after deducting... More
